Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBMG | MNPR | YDES | ||
| Company | Cellular Biomedicine | Monopar Therapeutics Inc | Yd Bio Limited | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 19.74 | 57.52 | 5.52 | ||
| High | 19.75 | 58.10 | 5.52 | ||
| Low | 19.73 | 55.92 | 5.20 | ||
| Latest | 19.75 | 57.70 | 5.30 | ||
| Change | unch | -0.21 | -0.13 | ||
| % Change | unch | -0.36% | -2.48% | ||
| Volume | 171,900 | 259,900 | 22,000 | ||
| 20-Day Average Volume | 197,580 | 183,715 | 28,115 | ||
| Previous Close | 19.75 | 57.91 | 5.43 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 19.27 | 55.93 | 6.64 | ||
| 20-Day Raw Stochastic | 99.77% | 71.44% | 4.93% | ||
| 20-Day Relative Strength | 67.50 | 50.47 | 34.61 | ||
| Weighted Alpha | +21.75 | +3.59 | -76.92 | ||
| Today's Opinion | 100% Buy | 56% Sell | N/A | ||
| Previous Opinion | 100% Buy | 56% Sell | N/A | ||
| Last Month's Opinion | 8% Sell | 40% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 02/11/21 | -0.38% since 04/09/26 | -8.30% since 04/09/26 | ||
| Low | 19.68 on 02/12/21 | 54.67 on 04/10/26 | 5.12 on 04/14/26 | ||
| High | 19.75 on 02/18/21 | 60.08 on 04/14/26 | 6.44 on 04/10/26 | ||
| 1-Month | |||||
| %Chg | +8.76% since 01/19/21 | -6.22% since 03/16/26 | -31.83% since 03/16/26 | ||
| Low | 17.60 on 01/28/21 | 50.47 on 04/07/26 | 5.12 on 04/14/26 | ||
| High | 19.75 on 02/18/21 | 64.86 on 03/17/26 | 8.77 on 03/24/26 | ||
| 3-Month | |||||
| %Chg | +7.63% since 11/19/20 | -17.57% since 01/16/26 | -53.18% since 01/16/26 | ||
| Low | 17.60 on 01/28/21 | 50.47 on 04/07/26 | 5.12 on 04/14/26 | ||
| High | 19.75 on 02/18/21 | 76.13 on 01/23/26 | 12.50 on 01/23/26 | ||
| 6-Month | |||||
| %Chg | +7.57% since 08/19/20 | -30.11% since 10/16/25 | -71.91% since 10/16/25 | ||
| Low | 16.98 on 11/06/20 | 50.47 on 04/07/26 | 5.12 on 04/14/26 | ||
| High | 19.75 on 02/18/21 | 100.50 on 11/24/25 | 22.00 on 10/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 384,691 | 387,540 | 383,282 | ||
| Shares Outstanding, K | 19,478 | 6,692 | 70,521 | ||
| Annual Sales | 340,000 | 0 | 510,360 | ||
| Annual Net Income | -49,980,000 | -13,720,000 | -1,411,559 | ||
| Last Quarter Sales | 30,000 | 0 | 186,000 | ||
| Last Quarter Net Income | -17,040,000 | -5,200,000 | 1,157,000 | ||
| 60-Month Beta | 1.17 | 1.64 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.61 on 03/27/26 | N/A | ||
| Latest Earnings Date | 02/26/21 | 05/12/26 | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||